These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3316283)

  • 1. Diagnosis of head and neck carcinomas by means of immunological tumour markers (Beta-2-microglobulin, immunoglobulin E, ferritin, N-acetyl-neuraminic acid, phosphohexose-isomerase).
    Vinzenz K; Schönthal E; Zekert F; Wunderer S
    J Craniomaxillofac Surg; 1987 Oct; 15(5):270-7. PubMed ID: 3316283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
    Fischer F; Egg G
    HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating markers in squamous cell carcinoma of the head and neck: a review.
    Rassekh CH; Johnson JT; Eibling DE
    Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):23-8. PubMed ID: 9135969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma antigen and protein-bound sialic acid in the management of head and neck cancer.
    Bhatavdekar JM; Patel DD; Vora HH; Balar DB
    Int J Biol Markers; 1991; 6(4):237-40. PubMed ID: 1795131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of the combined use of plurime tumor markers in human breast cancer.
    Neri B; Bartalucci S; Cataliotti L; Distante V; Tommasi M; Ciapini A
    Cancer Detect Prev; 1988; 13(2):115-21. PubMed ID: 3072081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck.
    Maxim PE; Veltri RW
    Cancer; 1986 Jan; 57(2):305-11. PubMed ID: 3942962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125.
    Straka MB; Wagner RL; Johnson JT; Kachman KK; Eibling DE
    Arch Otolaryngol Head Neck Surg; 1992 Aug; 118(8):802-5. PubMed ID: 1642830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
    Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD
    Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tumor markers of head and neck cancer: current status.
    Hanna EY; Papay FA; Gupta MK; Lavertu P; Tucker HM
    Head Neck; 1990; 12(1):50-9. PubMed ID: 2404906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
    Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
    Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum phosphohexose isomerase levels in patients with head and neck cancer.
    Goel H; Kohli GS; Lal H
    J Laryngol Otol; 1986 May; 100(5):581-5. PubMed ID: 3701205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CEA studies in squamous cell carcinomas of the head and neck].
    Schröder M; Meyer T
    HNO; 1986 Aug; 34(8):334-42. PubMed ID: 3759515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor-derived DNA may permit the early diagnosis of head and neck squamous cell carcinomas.
    Nunes DN; Kowalski LP; Simpson AJ
    Int J Cancer; 2001 Apr; 92(2):214-9. PubMed ID: 11291048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of intercellular adhesion molecule-1 in squamous cell carcinoma of the head and neck.
    Wollenberg B; Jan N; Sautier W; Hofmann K; Schmitt UM; Stieber P
    Tumour Biol; 1997; 18(2):88-94. PubMed ID: 9222306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck].
    Anderhuber W; Steinschifter W; Gotschuli A; Schauenstein E; Schauenstein K
    Laryngorhinootologie; 1998 Oct; 77(10):564-8. PubMed ID: 9842520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYFRA 8/18 in head and neck cancer.
    Maass JD; Niemann AM; Lippert BM; Gottschlich S; Folz BJ; Werner JA
    Anticancer Res; 1999; 19(4A):2699-701. PubMed ID: 10470223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
    Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
    Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Andersen JW
    Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of five circulating antigens in patients with head and neck squamous cell carcinoma.
    Screm MC; Grandis S; Cartei G; Cattaruzzi E
    Int J Biol Markers; 1989; 4(1):35-9. PubMed ID: 2501400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.